China approves AstraZeneca’s Tagrisso-chemo combo as first-line treatment
China approves AstraZeneca’s Tagrisso-chemo combo as first-line treatment
June 26 (Reuters) – China has approved the use of AstraZeneca’s (AZN.L) blockbuster cancer drug Tagrisso in combination with chemotherapy as a first line of treatment for adults with a type of advanced lung cancer, the company said on Wednesday.